2,878
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Neuroprotective effects of alkaloids from Piper longum in a MPTP-induced mouse model of Parkinson’s disease

, , , , , , , , & show all
Pages 1516-1524 | Received 26 Jul 2014, Accepted 21 Nov 2014, Published online: 10 Apr 2015

References

  • Barnham KJ, Masters CL, Bush AL. (2004). Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205–14
  • Bernard S, Romain Z, Patrick A. (2008). Viral vectors, animal models and new therapies for Parkinson’s disease. Parkinsonism Relat Disord 14:169–71
  • Bi Y, Wu X, Chen XQ. (2011). Progress in chemical constituents and pharmacology of Piper longum L. Chin Pharm J 46:1697–700
  • Carrozzo MM, Cannazza G, Pinetti D, et al. (2010). Quantitative analysis of acetylcholine in rat brain microdialysates by liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J Neurosci Methods 194:87–93
  • Ciobica A, Olteanu Z, Padurariu M, Hritcu L. (2012). The effects of pergolide on memory and oxidative stress in a rat model of Parkinson’s disease. J Physiol Biochem 68:59–69
  • Dickson DW, Fujishiro H, Orr C, et al. (2009). Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 15:S1–5
  • Dringen R. (2000). Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649–71
  • Garrett MC, Rosas MJ, Simoes F, et al. (1998). Does timing and dosage of levodopa modify drug-induced dyskinesias andmotor fluctuations? A retrospective analysis. Parkinsonism Relat Disord 4:99–102
  • Gaur V, Bodhankar SL, Mohan V, Thakurdesai PA. (2013). Neurobehavioral assessment of hydroalcoholic extract of Trigonella foenum-graecum seeds in rodent models of Parkinson’s disease. Pharm Biol 51:550–7
  • González RR, Fernández RF, Vidal JLM, et al. (2011). Development and validation of an ultra-high performance liquid chromatogra-phytandem mass-spectrometry (UHPLC–MS/MS) method for the simultaneous determination of neurotransmitters in rat brain samples. J Neurosci Methods 198:187–94
  • Hu SQ, Han RW, Mak SH, Han YF. (2011). Protection against 1-methyl-4-phenylpyridi-nium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C. A. Meyer) in SH-SY5Y cells. J Ethnopharmacol 135:34–42
  • Jiang ZY, Liu WF, Zhang XM, et al. (2013). Anti-HBV active constituents from Piper longum. Bioorg Med Chem Lett 23:2123–7
  • Khan MM, Raza SS, Javed H, et al. (2012). Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease. Neurotox Res 22:1–15
  • Kim IS, Koppula S, Park PJ, et al. (2009). Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. J Ethnopharmacol 126:447–54
  • Kim JS, Kim JM, O JJ, Jeon BS. (2010). Inhibition of inducible nitric oxide synthase expression and cell death by (−)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. J Clin Neurosci 17:1165–8
  • Kumar H, Lim HW, More SV, et al. (2012). The role of free radicals in the aging brain and Parkinson's disease: Convergence and parallelism. Int J Mol Sci 13:10478–504
  • Jenner P. (2007). Oxidative stress and Parkinson's disease. Handb Clin Neurol 83:507–20
  • Lee CS, Han ES, Kim YK. (2006). Piperine inhibition of 1-methyl-4-phenylpyri-dinium-induced mitochondrial dysfunction and cell death in PC12 cells. Eur J Pharmacol 537:37–44
  • Liu HL, Luo R, Chen XQ, et al. (2013). Tissue distribution profiles of three anti-Parkinsonian alkaloids from Piper longum L. in rats determined by liquidchromatography–tandem mass spectrometry. J Chromatogr B 928:78–82
  • Liu JH, Bi Y, Luo R, Wu X. (2011). Simultaneous UFLC-ESI-MS/MS determination of piperine and piperlonguminine in rat plasma after oral administration of alkaloids from Piper longum L.: Application to pharmacokinetic studies in rats. J Chromatogr B 879:2885–90
  • Ma J, Shaw VE, Mitrofanis J. (2008). Dose melatonin help save dopaminergic cells in MPTP-treated mice? Parkinsonism Relat Disord 13:1–8
  • Mu X, He GR, Yuan X, et al. (2011). Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice. Pharmacol Biochem Behav 98:286–91
  • Naghizadeh B, Mansouri MT, Ghorbanzadeh B, et al. (2013). Protective effects of oral crocin against intracerebroventricular streptozotocin-induced spatial memory deficit and oxidative stress in rats. Phytomedicine 20:537–42
  • Pattarini R, Rong Y, Qu C, Morgana JI. (2008). Distinct mechanisms of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyrmidine resistance revealed by transcriptome mapping in mouse striatum. Neuroscience 155:1174–94
  • Piyachaturawat P, Glinsukon T, Toskulkao C. (1983). Acute and subacute toxicity of piperine in mice, rats and hamsters. Toxicol Lett 16:351–9
  • Prakash B, Shukla R, Singh P, et al. (2010). Efficacy of chemically characterized Piper betle L. essential oil against fungal and aflatoxin contamination of some edible commodities and its antioxidant activity. Int J Food Microbiol 142:114–19
  • Schneider JS, Gonczi H, Decamp E. (2003). Development of levodopa-induced dyskinesias in Parkinsonian monkeys may depend upon rate of symptom onset and/or duration of symptoms. Brain Res 990:38–44
  • Sowell RA, Owen JB, Butterfield DA. (2009). Proteomics in animal models of Alzheimer’s and Parkinson’s diseases. Ageing Res Rev 8:1–17
  • Wang XL, Xing GH, Hong B, et al. (2014). Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: Involvement of ERK1/2-Nrf2 signaling pathway. Life Sci 114:77–85
  • Xu CL, Qu R, Zhang J, et al. (2013). Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats. Fitoterapia 90:112–18
  • Zhu KY, Fu Q, Leung KW, et al. (2011). The establishment of a sensitive method in determining different neurotransmitters simultaneously in rat brains by using liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B 879:737–42
  • Zhu Y, Zhang J, Zeng Y. (2012). Overview of tyrosine hydroxylase in Parkinson's disease. CNS Neurol Disord Drug Targets 11:350–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.